Back to Search
Start Over
Low expression of sodium iodide symporter expression in aggressive variants of papillary thyroid carcinoma.
- Source :
- International Journal of Clinical Oncology; Oct2014, Vol. 19 Issue 5, p800-804, 5p
- Publication Year :
- 2014
-
Abstract
- Background: A decreased radioiodine uptake is associated with high recurrence rate and reduced survival in papillary thyroid carcinoma (PTC). Sodium iodide symporter (NIS) expression status in aggressive PTC variants is unknown. Methods: NIS expression in conventional PTC and aggressive PTC variants such as tall cell variant (TCV) and diffuse sclerosing variant (DSPTC) was investigated using immunohistochemical detection. Results: Patients having TCV and DSPTC were significantly more likely to have extrathyroidal extension and lymph nodes metastases ( P < 0.05). Positive NIS staining was identified in 228 of 312 (73.1 %) patients with conventional PTC, 9 of 28 (32.1 %) patients with TCV and 12 of 30 (40.0 %) patients with DSPTC. NIS expression distinguished conventional PTC from TCV and DSPTC significantly ( P < 0.01). Conclusion: Due to their low NIS expression, TCV and DSPTC need higher cumulative doses of radioactive iodine therapy to improve their prognosis. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 13419625
- Volume :
- 19
- Issue :
- 5
- Database :
- Complementary Index
- Journal :
- International Journal of Clinical Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 98883011
- Full Text :
- https://doi.org/10.1007/s10147-013-0620-z